Nonblack patients with sickle cell disease have African. beta. sup s gene cluster haplotypes
- Univ. of Southern California School of Medicine, Los Angeles (USA)
- Duke Univ., Durham, NC (USA)
- California Institute of Technology, Pasadena (USA)
Of 18 nonblack patients with sickle cell disease, 14 had sickle cell anemia, 2 had hemoglobin SC disease, and 2 had hemoglobin S-{beta}{sup o}-thalassemia. The {beta}{sup s} gene cluster haplotypes that were determined in 7 patients were of African origin and were identified as Central African Republic, Central African Republic minor II, Benin, and Senegal. The haplotype Central African Republic minor II was present on the {beta}{sup o}-thalassemia chromosome in 2 patients. None of 10 patients whose {alpha}-gene status was determined had {alpha}-thalassemia-2. These data strongly support the concept that the {beta}{sup s} gene on chromosome 11 of these individuals is of African origin and that the {alpha}-gene locus on chromosome 16 is of white or native American origin. The clinical severity of the disease in these nonblack patients is appropriate to their haplotype without {alpha}-thalassemia-2 and is comparable with that of black patients. All persons with congenital hemolytic anemia should be examined for the presence of sickle cell disease regardless of physical appearance or ethnic background.
- OSTI ID:
- 7266775
- Journal Information:
- JAMA, Journal of the American Medical Association; (USA), Vol. 261:20; ISSN 0098-7484
- Country of Publication:
- United States
- Language:
- English
Similar Records
Locus control region HS2 point mutations are generally not responsible for elevated fetal hemoglobin expression of sickle cell patients
Genetic modulation of sickle cell anemia